Erlotinib Completed Phase 1 Trials for Cancer, Advanced Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 1 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT01287546 | A Study of LY2875358 in Participants With Advanced Cancer | |
NCT00895687 | Study of Erlotinib in Combination With Bortezomib | |
NCT00895128 | Study of Erlotinib in Combination With Dasatinib |